These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38895505)

  • 21. Increased activity of antagonists of growth hormone-releasing hormone substituted at positions 8, 9, and 10.
    Varga JL; Schally AV; Horvath JE; Kovacs M; Halmos G; Groot K; Toller GL; Rekasi Z; Zarandi M
    Proc Natl Acad Sci U S A; 2004 Feb; 101(6):1708-13. PubMed ID: 14755056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart.
    Granata R; Trovato L; Gallo MP; Destefanis S; Settanni F; Scarlatti F; Brero A; Ramella R; Volante M; Isgaard J; Levi R; Papotti M; Alloatti G; Ghigo E
    Cardiovasc Res; 2009 Jul; 83(2):303-12. PubMed ID: 19293247
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GHRH antagonists support lung endothelial barrier function.
    Uddin MA; Akhter MS; Singh SS; Kubra KT; Schally AV; Jois S; Barabutis N
    Tissue Barriers; 2019; 7(4):1669989. PubMed ID: 31578921
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GH-releasing hormone induces cardioprotection in isolated male rat heart via activation of RISK and SAFE pathways.
    Penna C; Settanni F; Tullio F; Trovato L; Pagliaro P; Alloatti G; Ghigo E; Granata R
    Endocrinology; 2013 Apr; 154(4):1624-35. PubMed ID: 23417421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of prostate-specific antigen (PSA) gene expression and release in LNCaP prostate cancer by antagonists of growth hormone-releasing hormone and vasoactive intestinal peptide.
    Rekasi Z; Schally AV; Plonowski A; Czompoly T; Csernus B; Varga JL
    Prostate; 2001 Aug; 48(3):188-99. PubMed ID: 11494334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Growth Hormone-Releasing Hormone in Endothelial Inflammation.
    Barabutis N; Akhter MS; Kubra KT; Jackson K
    Endocrinology; 2022 Dec; 164(2):. PubMed ID: 36503995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of NEK2 and NEK9 in LPS - induced endothelial barrier dysfunction.
    Barabutis N; Akhter MS
    Microvasc Res; 2024 Mar; 152():104651. PubMed ID: 38176677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A correlation of endocrine and anticancer effects of some antagonists of GHRH.
    Kovács M; Schally AV; Hohla F; Rick FG; Pozsgai E; Szalontay L; Varga JL; Zarándi M
    Peptides; 2010 Oct; 31(10):1839-46. PubMed ID: 20633588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of antagonists of growth hormone-releasing hormone with high and protracted in vivo activities.
    Varga JL; Schally AV; Csernus VJ; Zarándi M; Halmos G; Groot K; Rékási Z
    Proc Natl Acad Sci U S A; 1999 Jan; 96(2):692-7. PubMed ID: 9892695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effects of antagonists of growth hormone-releasing hormone on growth and invasiveness of PC3 human prostate cancer.
    Muñoz-Moreno L; Arenas MI; Schally AV; Fernández-Martínez AB; Zarka E; González-Santander M; Carmena MJ; Vacas E; Prieto JC; Bajo AM
    Int J Cancer; 2013 Feb; 132(4):755-65. PubMed ID: 22777643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of mutant p53 expression and growth of DMS-153 small cell lung carcinoma by antagonists of growth hormone-releasing hormone and bombesin.
    Kanashiro CA; Schally AV; Groot K; Armatis P; Bernardino AL; Varga JL
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15836-41. PubMed ID: 14660794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential involvement of signaling pathways in the regulation of growth hormone release by somatostatin and growth hormone-releasing hormone in orange-spotted grouper (Epinephelus coioides).
    Wang B; Qin C; Zhang C; Jia J; Sun C; Li W
    Mol Cell Endocrinol; 2014 Feb; 382(2):851-9. PubMed ID: 24183819
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of nitric oxide in the interferon-gamma-induced inhibition of growth hormone and prolactin secretion in anterior pituitary cell cultures.
    Vankelecom H; Matthys P; Denef C
    Mol Cell Endocrinol; 1997 May; 129(2):157-67. PubMed ID: 9202399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of acute and chronic administration of a new potent antagonist of growth hormone-releasing hormone in rats: mechanisms of action.
    Kovacs M; Zarándi M; Halmos G; Groot K; Schally AV
    Endocrinology; 1996 Dec; 137(12):5364-9. PubMed ID: 8940358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potentiation of the inhibitory effect of growth hormone-releasing hormone antagonists on PC-3 human prostate cancer by bombesin antagonists indicative of interference with both IGF and EGF pathways.
    Plonowski A; Schally AV; Varga JL; Rekasi Z; Hebert F; Halmos G; Groot K
    Prostate; 2000 Jul; 44(2):172-80. PubMed ID: 10881027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A glimpse at growth hormone-releasing hormone cosmos.
    Barabutis N
    Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1632-1634. PubMed ID: 32289177
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway.
    Rekasi Z; Czompoly T; Schally AV; Boldizsar F; Varga JL; Zarandi M; Berki T; Horvath RA; Nemeth P
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3435-40. PubMed ID: 15728367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hsp90 inhibitors suppress P53 phosphorylation in LPS - induced endothelial inflammation.
    Barabutis N; Uddin MA; Catravas JD
    Cytokine; 2019 Jan; 113():427-432. PubMed ID: 30420201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulational effect of ghrelin on growth hormone secretion from perifused rat anterior pituitary cells.
    Yamazaki M; Nakamura K; Kobayashi H; Matsubara M; Hayashi Y; Kangawa K; Sakai T
    J Neuroendocrinol; 2002 Feb; 14(2):156-62. PubMed ID: 11849375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alteration of the miRNA expression profile in male porcine anterior pituitary cells in response to GHRH and CST and analysis of the potential roles for miRNAs in regulating GH.
    Qi QE; Xi QY; Ye RS; Chen T; Cheng X; Li CY; Zhu XT; Shu G; Wang LN; Jiang QY; Zhang YL
    Growth Horm IGF Res; 2015 Apr; 25(2):66-74. PubMed ID: 25613666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.